Medicines, 2019
Shortlist up to four to read them side by side.
2,152 medicine recalls FDA’s Enforcement Report published in 2019, newest first; 18,075 in all since 2012.
FDA’s medicine recalls, as its Enforcement Report classifies them, from June 2012. Lists of FDA’s records can’t be saved for alerts: openFDA asks that its data not be used to alert the public (openFDA); FDA’s own emails do that. Copied Nov 5, 2026.
2,152of 2,152 medicine recallsshown with your filters
The list
- Medicine recall Clear Eyes Redness Relief, Product Size: 15 mL Lack of Assurance of Sterility Class IIFDA’s classNov 27, 2019in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedNov 27, 2019ClassClass IIStatusCompletedWhereNationwide
- Medicine recall Clear Eyes Redness Relief (Handy Pocket Pal), Product Size: 0.2 FL Lack of Assurance of Sterility Class IIFDA’s classNov 27, 2019in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedNov 27, 2019ClassClass IIStatusCompletedWhereNationwide
- Medicine recall Clear Eyes Redness Relief (Little Drug),Product Size: 0.2 FL Lack of Assurance of Sterility Class IIFDA’s classNov 27, 2019in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedNov 27, 2019ClassClass IIStatusCompletedWhereNationwide
- Medicine recall Calcarea Fluorica 6X Tablets, 300-count bottle, 30g CGMP Deviations: products were not manufactured under current good manufacturing practices. Class IIFDA’s classNov 27, 2019in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedNov 27, 2019ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Calcarea Phosphorica 6X Tablets, 300-count bottle, 30g CGMP Deviations: products were not manufactured under current good manufacturing practices. Class IIFDA’s classNov 27, 2019in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedNov 27, 2019ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Calcarea Sulphurica 6X Tablets, 300-count bottle, 30g CGMP Deviations: products were not manufactured under current good manufacturing practices. Class IIFDA’s classNov 27, 2019in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedNov 27, 2019ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Cell Salts Combination 6X Tablets, 300-count bottle, 30g CGMP Deviations: products were not manufactured under current good manufacturing practices. Class IIFDA’s classNov 27, 2019in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedNov 27, 2019ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Ferrum Phosphoricum 6X Tablets, 300-count bottle, 30g CGMP Deviations: products were not manufactured under current good manufacturing practices. Class IIFDA’s classNov 27, 2019in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedNov 27, 2019ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Kali Muriaticum 6X Tablets, 300-count bottle, 30g CGMP Deviations: products were not manufactured under current good manufacturing practices. Class IIFDA’s classNov 27, 2019in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedNov 27, 2019ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Kali Phosphoricum 6X Tablets, 300-count bottle, 30g CGMP Deviations: products were not manufactured under current good manufacturing practices. Class IIFDA’s classNov 27, 2019in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedNov 27, 2019ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Kali Sulphuricum 6X Tablets, 300-count bottle, 30g CGMP Deviations: products were not manufactured under current good manufacturing practices. Class IIFDA’s classNov 27, 2019in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedNov 27, 2019ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Magnesia Phosphorica 6X Tablets, 300-count bottle, 30g CGMP Deviations: products were not manufactured under current good manufacturing practices. Class IIFDA’s classNov 27, 2019in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedNov 27, 2019ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Natrum Muriaticum 6X Tablets, 300-count bottle, 30g CGMP Deviations: products were not manufactured under current good manufacturing practices. Class IIFDA’s classNov 27, 2019in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedNov 27, 2019ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Natrum Phosphoricum 6X Tablets, 300-count bottle, 30g CGMP Deviations: products were not manufactured under current good manufacturing practices. Class IIFDA’s classNov 27, 2019in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedNov 27, 2019ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Natrum Sulphuricum 6X Tablets, 300-count bottle, 30g CGMP Deviations: products were not manufactured under current good manufacturing practices. Class IIFDA’s classNov 27, 2019in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedNov 27, 2019ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Silicea 6X Tablets, 300-count bottle, 30g CGMP Deviations: products were not manufactured under current good manufacturing practices. Class IIFDA’s classNov 27, 2019in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedNov 27, 2019ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Pareira (Brava) 1X Tincture, 50 mL bottle, Washington Homeopathic Products, 260 JR Hawvermale Way, Berkeley… CGMP Deviations: products were not manufactured under current good manufacturing practices. Class IIFDA’s classNov 27, 2019in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedNov 27, 2019ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall StellaLife VEGA Oral Gel Rinse (In equal parts of: Azadirachta Indica 1x, Calendula Officinalis 1x, Echinacea… CGMP Deviations: products were not manufactured under current good manufacturing practices. Class IIFDA’s classNov 27, 2019in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedNov 27, 2019ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall R2103, Active Ingredients: Berberis Aquifolium 3x CGMP Deviations: products were not manufactured under current good manufacturing practices. Class IIFDA’s classNov 27, 2019in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedNov 27, 2019ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Formoterol 12mcg / Budesonide 0.5mg, 3.5ML Vial, For Inhalation Only, Shake Well, Conversio Health, San Luis… Lack of Processing Controls Class IIFDA’s classNov 27, 2019in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedNov 27, 2019ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Budesonide 0.4mg, 3ML Vial, For Inhalation Only, Conversio Health, San Luis Obispo, CA 93401. Lack of Processing Controls Class IIFDA’s classNov 27, 2019in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedNov 27, 2019ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Albuterol 3.75mg / Ipratropium 0.75mg, 3ML Vial, For Inhalation Only, Conversio Health, San Luis Obispo, CA… Lack of Processing Controls Class IIFDA’s classNov 27, 2019in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedNov 27, 2019ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Albuterol 2.5mg / Ipratropium 0.75mg, 2ML Vial, For Inhalation Only, Conversio Health, San Luis Obispo, CA… Lack of Processing Controls Class IIFDA’s classNov 27, 2019in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedNov 27, 2019ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Albuterol 2.5mg / Ipratropium 0.75mg /Budesonide 0.5mg, 3ML Vial, For Inhalation Only, Conversio Health, San… Lack of Processing Controls Class IIFDA’s classNov 27, 2019in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedNov 27, 2019ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Albuterol 2.5mg / Ipratropium 0.75mg /Budesonide 0.25mg, 3ML Vial, For Inhalation Only, Shake Well, Conversio… Lack of Processing Controls Class IIFDA’s classNov 27, 2019in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedNov 27, 2019ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Albuterol 2.5mg / Budesonide 0.5mg, 3ML Vial, For Inhalation Only, Shake Well, Conversio Health, San Luis… Lack of Processing Controls Class IIFDA’s classNov 27, 2019in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedNov 27, 2019ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Albuterol 1.25mg / Ipratropium 0.5mg/ Budesonide 0.25mg, 3ML Vial, For Inhalation Only, Conversio Health, San… Lack of Processing Controls Class IIFDA’s classNov 27, 2019in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedNov 27, 2019ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Albuterol 1.25mg / Ipratropium 0.5mg, 2ML Vial, For Inhalation Only, Conversio Health, San Luis Obispo, CA… Lack of Processing Controls Class IIFDA’s classNov 27, 2019in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedNov 27, 2019ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Albuterol 2.5mg / Ipratropium 0.75mg/ Triamcinolone 0.5 mg 3ML Vial, For Inhalation Only, Conversio Health,… Lack of Processing Controls Class IIFDA’s classNov 27, 2019in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedNov 27, 2019ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall 0.9% Sodium Chloride Irrigation USP 5000 mL bags Lack of Assurance of Sterility: Product has the potential to leak. Class IIFDA’s classNov 27, 2019in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedNov 27, 2019ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Valganciclovir Hydrochloride for Oral Solution, 50 mg/mL, 100 mL Presence of foreign substance: Brown/black particles found during stability testing. Class IIFDA’s classNov 27, 2019in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedNov 27, 2019ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Levetiracetam Injection, 500 mg/5mL, 10 single-use 5 mL vials Labeling: Incorrect or Missing Package Insert - the incorrect package insert version was attached. Class IIIFDA’s classNov 27, 2019in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedNov 27, 2019ClassClass IIIStatusTerminatedWhereNationwide
- Medicine recall GSMS: Ranitidine Capsules 150 mg CGMP Deviations: Presence of NDMA impurity detected in product. Class IIFDA’s classNov 20, 2019in FDA’s Enforcement Report4 statesnamed in where it went PublishedNov 20, 2019ClassClass IIStatusTerminatedWhereArizona, Iowa, Massachusetts and Missouri
- Medicine recall GSMS: Ranitidine Capsules 300 mg CGMP Deviations: Presence of NDMA impurity detected in product. Class IIFDA’s classNov 20, 2019in FDA’s Enforcement Report4 statesnamed in where it went PublishedNov 20, 2019ClassClass IIStatusTerminatedWhereArizona, Iowa, Massachusetts and Missouri
- Medicine recall Lannett Ranitidine Syrup (Ranitidine Oral Solution, USP), 15mg/mL CGMP Deviations: Presence of NDMA impurity detected in product. Class IIFDA’s classNov 20, 2019in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedNov 20, 2019ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Novitium Pharma Ranitidine Capsules 150 mg 60 capsules CGMP Deviations: Presence of NDMA impurity detected in product. Class IIFDA’s classNov 20, 2019in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedNov 20, 2019ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Novitium Pharma Ranitidine Capsules 150 mg 500 capsules CGMP Deviations: Presence of NDMA impurity detected in product. Class IIFDA’s classNov 20, 2019in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedNov 20, 2019ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Novitium Pharma Ranitidine Capsules 300 mg 30 capsules CGMP Deviations: Presence of NDMA impurity detected in product. Class IIFDA’s classNov 20, 2019in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedNov 20, 2019ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Novitium Pharma Ranitidine Capsules 300 mg 100 capsules CGMP Deviations: Presence of NDMA impurity detected in product. Class IIFDA’s classNov 20, 2019in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedNov 20, 2019ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Walgreens Maximum Strength Wal-Zan 150 Ranitidine Tablets, USP 150 mg/Acid Reducer GGMP Deviations: Possible contamination with impurity N-nitrosodimethylamine (NDMA). Class IIFDA’s classNov 20, 2019in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedNov 20, 2019ClassClass IIStatusCompletedWhereNationwide
- Medicine recall Walgreens Regular Strength Wal-Zan 75 Ranitidine Tablets, USP 75 mg/Acid Reducer 30 Tablets GGMP Deviations: Possible contamination with impurity N-nitrosodimethylamine (NDMA). Class IIFDA’s classNov 20, 2019in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedNov 20, 2019ClassClass IIStatusCompletedWhereNationwide
- Medicine recall Equate Maximum Strength Ranitidine Tablets, USP 150 mg Acid Reducer 130 Tablets GGMP Deviations: Possible contamination with impurity N-nitrosodimethylamine (NDMA). Class IIFDA’s classNov 20, 2019in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedNov 20, 2019ClassClass IIStatusCompletedWhereNationwide
- Medicine recall Rite Aid Pharmacy Maximum Strength Ranitidine Tablets, USP 150 mg Cool Mint Acid Reducer 24 Tablets Sugar Free GGMP Deviations: Possible contamination with impurity N-nitrosodimethylamine (NDMA). Class IIFDA’s classNov 20, 2019in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedNov 20, 2019ClassClass IIStatusCompletedWhereNationwide
- Medicine recall Equate Maximum Strength Ranitidine Tablets, USP 150 mg Acid Reducer Cool Mint Tablets Sugar Free 65 Tablets GGMP Deviations: Possible contamination with impurity N-nitrosodimethylamine (NDMA). Class IIFDA’s classNov 20, 2019in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedNov 20, 2019ClassClass IIStatusCompletedWhereNationwide
- Medicine recall Rite Aid Pharmacy Maximum Strength Ranitidine Tablets, USP 150 mg-acid reducer GGMP Deviations: Possible contamination with impurity N-nitrosodimethylamine (NDMA). Class IIFDA’s classNov 20, 2019in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedNov 20, 2019ClassClass IIStatusCompletedWhereNationwide
- Medicine recall Isotretinoin Capsules, USP 10 mg Failed Impurities/Degradation Specifications: Tretinoin levels slightly above specification limits. Class IIIFDA’s classNov 20, 2019in FDA’s Enforcement ReportNot namedno state, in where it went PublishedNov 20, 2019ClassClass IIIStatusTerminatedWhereNo state named
- Medicine recall Zentrip (meclizine Hydrochloride), 25 mg strips, 8-strips per box Subpotent Drug Class IIIFDA’s classNov 20, 2019in FDA’s Enforcement ReportNationwideFDA’s word, and 2 states named PublishedNov 20, 2019ClassClass IIIStatusTerminatedWhereNationwide, and Guam and Northern Mariana Islands named
- Medicine recall Motion Sickness (meclizine hydrochloride) 25 mg tablets, 12-count box Subpotent Drug Class IIIFDA’s classNov 20, 2019in FDA’s Enforcement ReportNationwideFDA’s word, and 2 states named PublishedNov 20, 2019ClassClass IIIStatusTerminatedWhereNationwide, and Guam and Northern Mariana Islands named
Nothing matches all of these.
Remove a filter to see more. Each one is a fact FDA’s record publishes, so a recall can be left out because its record is silent on it.
Source:
FDA, Drug recall enforcement reports. Released Nov 3, 2026. Updated weekly.
Recalls of food, medicines, medical devices, pet food and animal drugs are from the U.S. Food and Drug Administration (FDA). FDA does not endorse Hearth Record. openFDA: “Do not rely on openFDA to make decisions regarding medical care.”
Your shortlist0 of 4
Add one more to compare.